Mamaroneck, NY, United States of America

Eileen Geoghegan

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Actinium Pharmaceuticals, Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eileen Geoghegan. Retrieved from https://idiyas.com/inventor/eileen-geoghegan-l8qb402o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eileen Geoghegan: Innovator in Cancer Treatment

Introduction

Eileen Geoghegan is a notable inventor based in Mamaroneck, NY (US). She has made significant contributions to the field of cancer treatment through her innovative work. Her dedication to advancing medical technology has led to the development of a unique patent that addresses critical health challenges.

Latest Patents

Eileen Geoghegan holds a patent for "Lewis Y Radioimmunotherapy for the Treatment of Cancer." This groundbreaking invention represents a significant step forward in the fight against cancer, showcasing her commitment to improving patient outcomes.

Career Highlights

Eileen is currently associated with Actinium Pharmaceuticals, Limited, where she applies her expertise to develop innovative therapies. Her work at the company emphasizes her role in advancing cancer treatment options and highlights her contributions to the pharmaceutical industry.

Conclusion

Eileen Geoghegan's innovative spirit and dedication to cancer research make her a prominent figure in the field. Her patent and work with Actinium Pharmaceuticals, Limited, reflect her commitment to improving healthcare through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…